Analysis of transcutaneous antigenic protein delivery by a hydrogel patch formulation

Journal of Pharmaceutical Sciences

Volumn 102, Issue 6, 2013, Pages 1936-1947

  Matsuo, Kazuhiko ^a   Ishii, Yumiko ^a   Kawai, Yasuaki ^a   Saiba, Yuki ^a   Quan, Ying Shu ^b   Kamiyama, Fumio ^b   Hirobe, Sachiko ^a   Okada, Naoki ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b CosMED Pharmaceutical Company Ltd ^*  (Japan)

Author keywords

Hydrogel patch; Percutaneous; Protein delivery; Skin; Transcutaneous immunization; Vaccine delivery; Vaccine device; Vaccines

Indexed keywords

ANTIGEN; GLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HYDROGEL; LANGERHANS CELL; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; STRATUM CORNEUM; TRANSDERMAL PATCH;

EID: 84877920569     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23540     Document Type: Article

References (22)

1. Glenn GM, Scharton-Kersten T, Alving CR. 1999. Advances in vaccine delivery: Transcutaneous immunisation. Expert Opin Invest Drugs 8:797-805.
2. Levine MM. 2003. Can needle-free administration of vaccines become the norm in global immunization? Nat Med 9:99-103.
3. Mathers AR, Larregina AT. 2006. Professional antigen-presenting cells of the skin. Immunol Res 36:127-136.
4. Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P. 2003. Langerhans cells-Dendritic cells of the epidermis. APMIS 111:725-740.
5. Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L, Ronchese F, Romani N. 2006. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 103:7783-7788.
6. Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, Tokura Y. 2007. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 147:176-183.
7. Wu C, Li C, Wei L, Zheng Z. 2008. Innate immune modulation of keratinocytes by antikeratin 16 antibodies. Exp Dermatol 17:645-652.
8. Ishii Y, Nakae T, Sakamoto F, Matsuo K, Matsuo K, Quan YS, Kamiyama F, Fujita T, Yamamoto A, Nakagawa S, Okada N. 2008. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection. J Control Release 131:113-120.
9. Matsuo K, Ishii Y, Quan YS, Kamiyama F, Mukai Y, Yoshioka Y, Okada N, Nakagawa S. 2011. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat. J Control Release 149:15-20.
10. Matsuo K, Ishii Y, Quan YS, Kamiyama F, Mukai Y, Okada N, Nakagawa S. 2011. Characterization of transcutaneous protein delivery by a hydrogel patch in animal, human, and tissue-engineered skin models. Biol Pharm Bull 34:586-589.
11. Matsuo K, Ishii Y, Quan YS, Kamiyama F, Asada H, Mukai Y, Okada N, Nakagawa S. 2011. Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device. Biol Pharm Bull 34:1835-1840.
12. Hirobe S, Matsuo K, Quan YS, Kamiyama F, Morito H, Asada H, Takaya Y, Mukai Y, Okada N, Nakagawa S. 2012. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria. Vaccine 30:1847-1854.
13. Mackenzie IC, Squier CA. 1975. Cytochemical identification of ATPase-positive langerhans cells in EDTA-separated sheets of mouse epidermis. Br J Dermatol 92:523-533.
14. Bergstedt-Lindqvist S, Moon HB, Persson U, Möller G, Heusser C, Severinson E. 1988. Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE. Eur J Immunol 18:1073-1077.
15. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. 1998. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 140:1022-1027.
16. Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka AK, Reiter Y, Banchereau J, Ueno H. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29:497-510.
17. Nakajima S, Igyártó BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M, Watanabe N, Ziegler SF, Tomura M, Inaba K, Miyachi Y, Kaplan DH, Kabashima K. 2012. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 129:1048-1055.
18. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169:569-576.
19. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F, Pamer EG, Littman DR, Lang RA. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17:211-220.
20. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhé C, Perrin P, Roman N, Tripp CH, Douillard P, Leserman L, Kaiserlian D, Saeland S, Davoust J, Malissen B. 2005. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643-654.
21. Hood HL, Kraeling ME, Robl MG, Bronaugh RL. 1999. The effects of an alpha hydroxy acid (glycolic acid) on hairless guinea pig skin permeability. Food Chem Toxicol 37:1105-1111.
22. Bert J, Reed RK. 1998. Hyaluronan, hydration and flow conductivity of rat dermis. Biorheology 35:211-219.